Skip to content

Author

Yu Fujiwara

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards.

Evidence is accumulating to support feasibility and survival benefit in patients treated with matched therapy, and the incorporation of molecular targeted therapies and immunotherapy into the perioperative setting requires clinicians to understand the role of the MTB.

Yu Fujiwara, S. Kato, R. Kurzrock · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.